Evidence map›Paper›PMID 27729076›Full record

ArticleBMC health services research2016

Health worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study.

Olatunde Adesoro, Constance Shumba, John Kpamor, Jane Achan, Harriet Kivumbi, John Dada, Kolawole Maxwell, James Tibenderana, Madeline Marasciulo, Prudence Hamade and 3 more

Abstract read
In one paragraph

Article in BMC health services research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Olatunde AdesoroMalaria Consortium Nigeria, 3rd Floor, Abia House, Off Ahmadu Bello Way, Central Business District, Abuja, F.C.T., Nigeria. o.adesoro@malariaconsortium.org.ORCID 0000-0002-5619-7821
Constance ShumbaMalaria Consortium Africa Region, P.O Box 8045, Kampala, Uganda.
John KpamorMalaria Consortium Nigeria, 3rd Floor, Abia House, Off Ahmadu Bello Way, Central Business District, Abuja, F.C.T., Nigeria.
Jane AchanMedical Research Council Unit The Gambia, P.O Box 273, Serrekunda, The Gambia.
Harriet KivumbiMalaria Consortium Africa Region, P.O Box 8045, Kampala, Uganda.
John DadaMalaria Consortium Nigeria, 3rd Floor, Abia House, Off Ahmadu Bello Way, Central Business District, Abuja, F.C.T., Nigeria.
Kolawole MaxwellMalaria Consortium Nigeria, 3rd Floor, Abia House, Off Ahmadu Bello Way, Central Business District, Abuja, F.C.T., Nigeria.
James TibenderanaMalaria Consortium Africa Region, P.O Box 8045, Kampala, Uganda.
Madeline MarasciuloMalaria Consortium, Development House, 56-64 Leonard Street, London, EC2A 4LT, UK.
Prudence HamadeMalaria Consortium, Development House, 56-64 Leonard Street, London, EC2A 4LT, UK.
Olusola OresanyaMalaria Consortium Nigeria, 3rd Floor, Abia House, Off Ahmadu Bello Way, Central Business District, Abuja, F.C.T., Nigeria.
Joanita NankabirwaMalaria Consortium Africa Region, P.O Box 8045, Kampala, Uganda.
Ebenezer BabaMalaria Consortium Africa Region, P.O Box 8045, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInnovative strategies are needed to reduce malaria mortality in high burden countries like Nigeria. Given that one of the important reasons for this high malaria mortality is delay in receiving effective treatment, improved access to such treatment is critical. Intramuscular artesunate could be used at lower-level facilities given its proven efficacy, ease of use and excellent safety profile. The objective of this study was therefore to explore health workers' perspectives on the possible use of intramuscular artesunate as definitive treatment for severe malaria at lower-level facilities, especially when access to referral facilities is challenging. The study was to provide insight as a formative step into the conduct of future experimental studies to ascertain the feasibility of the use of intramuscular artesunate for definitive treatment of severe malaria in lower level facilities where access to referral care is limited.

methodsThis qualitative study was done across three southern States in Nigeria (Oyo, Cross River and Enugu). Key informant interviews were conducted over a period of three months between October and December 2014 among 90 purposively selected health workers with different roles in malaria case management from primary care to policy level. A thematic content analysis was used to analyse data.

resultsOverall, most of health workers and other key informant groups thought that the use of intramuscular artesunate for definitive treatment of severe malaria at lower-level facilities was possible. They however reported human resource and infrastructure constraints as factors affecting the feasibility of intramuscular artesunate use as definitive treatment for severe malaria in lower-level facilities.. Specifically identified barriers included limited numbers of skilled health workers available to manage potential complications of severe malaria and poorly equipped facilities for supportive treatment. Intramuscular artesunate was considered easy to administer and the proximity of lower-level facilities to communities was deemed important in considering the possibility of its use at lower-level facilities. Health workers also emphasised the important role of operational research to provide additional evidence to guide the implementation of existing policy recommendations and inform future policy revisions.

conclusionsFrom the perspective of health workers, use of intramuscular artesunate for definitive treatment of severe malaria at lower-level health facilities in Nigeria is possible but dependent on availability of skilled workers, well-equipped lower-level facilities to provide supportive treatment There is need for further operational research to establish feasibility and guide the implementation of such an intervention.

Indexed as

Attitude of Health PersonnelHealth FacilitiesHealth PersonnelAdultAntimalarialsArtemisininsArtesunateCase ManagementFemaleHumansInjections, IntramuscularInterviews as TopicMalariaMaleMiddle AgedNigeriaAntimalarialsArtemisininsArtesunateIntramuscular artesunateLower-level facilitiesPoor referral systemsQualitative studySevere malaria

Identifiers

PMID27729076
PMCPMC5059903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.